COVID-19 response

March 26, 2020

During this time of uncertainty, we want our patients to know that Cape Girardeau Urology Associates is committed to providing you with the medical care you need.  We want to reassure you of some additional measures our staff is taking to keep our patients, staff, and clinicians safe.

  • Schedules are being reviewed to identify non-urgent procedures. Non-urgent procedures are being rescheduled to conserve scarce resources for those who are sick and to reduce your risk of becoming exposed to COVID-19.  If your surgery is affected, a member of our staff will contact you.
  • Our medical staff is also identifying patient office visits that can be effectively managed through telemedicine.
    • Due to the recent update of government guidelines, we are able to offer the telemedicine option.  This type of visit is conducted in the comfort and safety of your home.
    • Any device that can access the internet through Google Chrome, Firefox, or Safari and has audio/visual capability, should work for these video visits.
    • These visits are billed to your insurance carrier and normal co-pays will apply.  Medicare and other carriers have announced they will cover telemedicine visits.  If you have questions about coverage under your specific plan, you should contact your insurance carrier.
    • If your appointment has been selected for a telehealth visit, you will be contacted by a member of our staff.
  • We are implementing a COVID-19 verbal screening. Patients with in-office appointments will be called the day before their appointment and will be ask a series of questions regarding symptoms and possible exposure.
  • We are asking patients to wash their hands upon entering the building and hand sanitizer is located at each front window.
  • We have removed all communal waiting room items such as magazines, pens, etc. Frequent cleaning and disinfecting in waiting areas and restrooms, etc., is being performed in addition to the routine disinfecting of all exam rooms after each patient.

We continue to closely monitor the current situation and developments from the CDC and will continue implementing those recommendations.